Ampio initiates pivotal Ampion osteoarthritis trial

Ampio initiates pivotal Ampion osteoarthritis trial

ENGLEWOOD -- Ampio Pharmaceuticals, Inc . (NYSE MKT: AMPE) announced it has begun a single injection study to meet the unmet medical need of treating the severe pain and loss of function... Read More

Monday May 1, 2017 Tags: Englewood, Ampio Pharmaceuticals, Ampion, Dr. David Bar-Or, Chris Ehrlich, Michael Macaluso

IN Sponsors

Content Garden ad

Browse

InnovatioNews ends 9-year run covering Colorado innovation
A New Sunrise. Stakeholders all await, shapes a path to success too few even see. How often you get & answer questions is one indicator of your readiness
A New Sunrise. Stakeholders all await, shapes a path to success too few even see. How often you get & answer questions is one indicator of your readiness
InnovatioNews on Spring hiatus until May 13
InnovatioNews on Spring hiatus until May 13
The Coming Drone Delivery Revolution – What Comes Next?
The Coming Drone Delivery Revolution – What Comes Next?
Primavera Essentials introduces Neuro-Eze
Primavera Essentials introduces Neuro-Eze

Entrepreneurial by Nature


Colorado Entreprenerial by Nature
Copyright InnovatioNews LLC 2015. All Rights Reserved.